MedPath

The effect of exercise intensity and supplementation on diabetes

Not Applicable
Conditions
Type 2 diabetes.
Type 2 diabetes mellitus
Registration Number
IRCT20180711040425N1
Lead Sponsor
Shahroud University of Technology
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
60
Inclusion Criteria

T2D detection < 10 years ago
Ages 40 to 65 years old
No dependency to insulin
The use of commonly used diabetes medications, such as metformin and glenalbelamine

Exclusion Criteria

Cardiovascular disease
Coronary artery disease
Atrial fibrillation
High blood pressure
Congenital heart disease
Retinopathy
Neuropathy
Body mass index 35
Ischemia in echocardiography
Disability that causes difficulty in practice.

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Serum levels of Malondialdehyde in women with type 2 diabetes. Timepoint: One day before the session begins and 48 hours after the end of the exercise. Method of measurement: The MDA level measurement will be performed by ELISA, using a commercially available chemical calorimetry laboratory kit (MDA test kit; ZellBio GmbH, Ulm, Germany).;Serum Total Antioxidant Capacity in women with type 2 diabetes. Timepoint: One day before the session begins and 48 hours after the end of the exercise. Method of measurement: The serum level of antioxidant total capacity will be measured by ELISA and using a commercial kit under the manufacturer's protocols (ZellBio GmbH, Germany).
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath